Assessing the function of mTOR in human embryonic stem cells

Methods Mol Biol. 2012:821:361-72. doi: 10.1007/978-1-61779-430-8_23.

Abstract

We described a protocol for dissecting the function of an important serine/threonine protein kinase, mammalian target of rapamycin (mTOR), in regulating the long-term undifferentiated growth of human embryonic stem cells (hESCs). The function of mTOR in hESCs was inactivated with a highly specific chemical inhibitor, rapamycin, and gene-specific small-hairpin RNAs, and the effects were evaluated under self-renewal or early differentiation conditions. We found that inactivation of mTOR impairs proliferation and enhances mesoderm and endoderm activities of hESCs. This protocol described a general strategy for studying the function of key genes and signaling events during hESC long-term self-renewal and early lineage specifications with pharmacological and genetic approaches.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Cell Differentiation*
  • Cell Lineage / drug effects
  • Cell Proliferation / drug effects
  • Embryonic Stem Cells / cytology*
  • Embryonic Stem Cells / enzymology*
  • Endoderm / cytology
  • Endoderm / drug effects
  • Gene Knockdown Techniques
  • HEK293 Cells
  • Humans
  • Mesoderm / cytology
  • Mesoderm / drug effects
  • Mice
  • RNA, Small Interfering / genetics
  • Signal Transduction
  • Sirolimus / pharmacology
  • TOR Serine-Threonine Kinases / antagonists & inhibitors*
  • TOR Serine-Threonine Kinases / genetics
  • TOR Serine-Threonine Kinases / physiology*

Substances

  • RNA, Small Interfering
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Sirolimus